Objective To evaluate the efficacy and safety of traditional Chinese medicine(TCM)paste in treating chronic obstructive pulmonary disease(COPD)in stable stage.Methods We electronically searched databases including PubMed,EMbase,the Cochrane Library,VIP,Wan Fang,CNKI,and CBM to collect randomized controlled trials(RCTs)regarding TCM paste in combination with conventional Western therapy versus Western therapy alone in treating stable COPD from inception to December 2016.Two reviewers independently screened literature,extracted data and assessed risk of bias of the included studies.The meta-analysis was conducted by RevMan 5.3 software.Results A total of 9 RCTs involving 605 Chinese patients were included.Conclusion showed that:in comparison with conventional Western medicine alone,TCM paste combined with the conventional Western medicine significantly improved clinical effective rate(RR=1.20,95%CI 1.10 to 1.31,P<0.0001),decreased SGRQ score(MD=-4.53,95%CI-5.41 to-3.65,P<0.000 01)and CAT score(MD=-2.45,95%CI-3.38 to-1.51,P<0.000 01),increased FEV1%(MD=3.80,95%CI 0.40 to 7.20,P=0.03),and reduced the frequency of acute exacerbation(P<0.05).No serious adverse reaction occurred in both groups.Conclusion Current evidence shows that combination of TCM paste and conventional Western medicine may improve clinical effective rate,quality of life,increase FEV1%,and reduce the frequency of acute exacerbation in patients with stable COPD.Due to the variety of TCM paste and western medicine and limited methodological quality of the included studies,more high-quality RCTs with large scale are needed.